Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Janux Therapeutics Inc (JANX)
NASDAQ:JANX
RESEARCH TOOLSreports
Holding JANX?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 439.00K | $ 8.90M | $ 1.25M | $ 2.46M | $ 2.52M |
| Gross Profit | $ 439.00K | $ 8.90M | $ 1.25M | $ 2.46M | $ 2.52M |
| EBIT | $ -28.06M | $ -5.96M | $ -20.16M | $ -16.14M | $ -15.81M |
| EBITDA | $ -27.55M | $ -3.67M | $ -19.63M | $ -15.61M | $ -15.31M |
| Net Income Common Stockholders | $ -28.06M | $ -5.96M | $ -14.76M | $ -11.76M | $ -11.57M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 658.03M | $ 646.29M | $ 651.76M | $ 344.03M | $ 349.71M |
| Total Assets | $ 695.02M | $ 691.41M | $ 688.98M | $ 380.41M | $ 386.85M |
| Total Debt | $ 23.43M | $ 23.82M | $ 24.18M | $ 24.54M | $ 24.89M |
| Net Debt | $ -634.60M | $ -622.47M | $ -627.58M | $ -319.49M | $ -324.82M |
| Total Liabilities | $ 38.91M | $ 33.73M | $ 33.22M | $ 36.06M | $ 37.90M |
| Stockholders Equity | $ 656.10M | $ 657.66M | $ 655.76M | $ 344.35M | $ 348.95M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -2.26M | $ -10.12M | $ -15.03M | $ -10.42M | $ -12.18M |
| Operating Cash Flow | $ -2.23M | $ -10.02M | $ -14.84M | $ -9.90M | $ -11.71M |
| Investing Cash Flow | $ 12.67M | $ -190.88M | $ -113.74M | $ 11.12M | $ -61.45M |
| Financing Cash Flow | $ 1.65M | $ 2.77M | $ 322.17M | $ 831.00K | $ 56.61M |